65,437 trials
Psoriasis
Primary: Percentage of Participants Achieving Psoriasis Area and Severity Index ≥75% (PASI 75) Improvement — 7.7; 28.6; 76.7; 82.8 percentage of participants — p=0.079
Rheumatoid Arthritis
Primary: DB Period: Change From Baseline in Disease Activity Score for 28 Joints - Erythrocyte Sedimentation Rate (DAS28-ESR) Score at Week 24 — -2.20; -3.28 units on a scale…
Periapical Diseases
Primary: Changes Between Initial and Post Treatment Dimensions of Periapical Lesions — 37.34; 34.04; 16.20; 17.54 square millimeters — p=<0.01
Pain, Postoperative · Postoperative Nausea and Vomiting
Primary: Morphine Consumption at 24 Hours Post-op — 15; 13.75 milligram — p=0.740
Human Immunodeficiency Virus · Immune Reconstitution Inflammatory Syndrome
Primary: All-cause Mortality — 21; 18 participants
Pain
Primary: Patient Perception of Pain — 60; 68; 56; 63 mm
Hemophilia B
Primary: Mean Difference of Area Under the Curve (AUC): BeneFIX Compared to AlphaNine — 10.41 IU x hour/dL — p=0.77
Diabetes · Cardiovascular Risk Factor
Primary: Changes in Weight Between Baseline and Post-intervention (Assessed at 6 Months After Commencement of Intervention) Compared to Delayed Intervention Participants…
Adult Rhabdomyosarcoma · Childhood Alveolar Rhabdomyosarcoma · Childhood Botryoid-Type Embryonal Rhabdomyosarcoma
Primary: Event Free Survival (EFS) — 0.6255; 0.5874 Probability
Pancreatic Cancer
Primary: To Determine the Sensitivity High Resolution Magnetic Resonance Imaging With Lymphotrophic Superparamagnetic Nanoparticles to Identify Small and Otherwise Undetectable…
Systemic Lupus Erythematosus
Primary: Percentage of Par. Achieving a SLE Responder Index (SRI) Response Rate at Week 52 — 48.4; 61.4 Percentage of par. — p=0.0006
Migraine
Primary: Pharmacokinetics Outcome (1 of 6) — 1411.96; 0.00; 649.78; 1123.88 ng/mL
Post-op Pain
Primary: Total Post-operative Use of Opioids — 21.7; 21.7 Morphine milligram equivalents (MME)
Post Traumatic Stress Disorder
Primary: Internalized Stigma of Mental Illness Inventory (Internalized Stigma) — 2.5; 2.6; 2.1; 2.5 units on a scale
Human Gut Microbiota
Primary: Bacteria Prevalence in Stool — 22.3; 20.9; 18.0; 25.5 percentage of bacterial genera in stool — p=<0.05